Innovus (INNV) Conference Call Transcript.
Q1 2019 Results, 5/15/19.
Innovus Pharmaceuticals, Inc. (OTCQB:INNV) Q1 2019 Earnings Conference Call May 15, 2019 4:15 PM ET
Company Participants
Bassam Damaj - President and CEO
Ryan...
Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)
(Originally published 4/25/2018)
“I am very steady. I like to work slowly, but surely, to get to my goal.” Thus speaks Bassam Damaj, president and...
Beyonce Tells Uber “Pay me in Stock!”
We all know Beyoncé is brilliant, but this move she made in 2015 may be the absolute ultimate in future planning. Four years ago, Beyoncé...
Adding Innovus Pharma (INNV) $2.50 to Watch List.
Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its lineup.
We're adding...
Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.
CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided...
Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.
Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or...
Making the TASE and Israeli Stocks Sound Sexy Once Again.
IF YOU WANT TO BEAT THE S&P 500, INVEST IN AN ISRAELI ETF
Tracking the charts for the past 30 years, Steven Schoenfeld says that...
Kevin Bidner’s Hotel Communication Network.
Click to Read About the Most Exciting Internet Powered Media Network (Advertising) We've Seen in Decades.
The last time we saw a network like this...
Lift Off! Mustang Bio (MBIO) $9.31 Jumps 4-Fold.
‘Bubble Boy’ Biotech Soars 250 Percent After Cure Announcement (Bloomberg).
(Bloomberg) -- Shares of the tiny biotechnology company Mustang Bio Inc. more than tripled Thursday,...
Dyadic (DYAI) Uplists to NASDAQ!
JUPITER, FL / ACCESSWIRE / April 15, 2019 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying...
Latest article
Jeffrey Gundlach: Reckoning is Coming.
Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm.
On 11 November 2020, Gundlach remarked in an interview with...
Who’s the Next Eric Sprott?
To say Eric Sprott has left a legendary mark on the world of mining investment would be an understatement. With a career spanning five...
Perpetua (PPTA) Raises $300 Million.
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...
